In an independent patient cohort, the levels of GLO1 were significantly higher in PCa patients compared to BPH patients (FC = 3.10, p = 0.0017, AUC = 0.73) (Figure 3F). This evidence concerns the gene GLO1 and benign prostatic hyperplasia.